Vaccines

14 Jun 2020 AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
14 Jun 2020 Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
13 Jun 2020 Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials
13 Jun 2020 FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
11 Jun 2020 Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
11 Jun 2020 Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III
11 Jun 2020 Catalent Partners with Spicona to Develop COVID-19 Vaccine Candidate using GPEx Cell Line Development Platform
10 Jun 2020 Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July
10 Jun 2020 Panacea Biotec and Refana Announce Landmark Collaboration for COVID-19 Vaccine
10 Jun 2020 UbiVac Announces Clinical Trial Collaboration with Bristol Myers Squibb on Combination Immunotherapy for Advanced Triple Negative Breast Cancer
08 Jun 2020 Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
08 Jun 2020 The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
05 Jun 2020 PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Advanced Cervical Cancer
05 Jun 2020 Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
05 Jun 2020 Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine
05 Jun 2020 AstraZeneca takes next steps towards broad and equitable access to Oxford University’s COVID-19 vaccine
04 Jun 2020 INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea
03 Jun 2020 Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine
01 Jun 2020 Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19
01 Jun 2020 Coronavirus Vaccine Development Underway by Vault Pharma
31 May 2020 Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation
31 May 2020 MimiVax Phase 2 study of SurVaxM in combination with pembrolizumab opens for recurrent glioblastoma patients
30 May 2020 Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
29 May 2020 Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen
29 May 2020 Clinical Response and Translational Data from DeCidE1, a Phase 2 Study of DPX-Survivac Immunotherapy in Patients with Advanced Recurrent Ovarian Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top